Learning to match patients to clinical trials using large language models.
Maciej Rybinski1, Wojciech Kusa2, Sarvnaz Karimi1
1CSIRO, Data61, 26 Pembroke Rd, Marsfield, 2122, NSW, Australia.
Journal of Biomedical Informatics
|October 10, 2024
Summary
Large Language Models (LLMs) significantly improve patient-to-clinical trial matching by enhancing semantic analysis in retrieval pipelines. While LLM-based re-ranking shows superior effectiveness, it increases computational costs, necessitating a balance for practical application.
Area of Science:
- Information Retrieval
- Natural Language Processing
- Clinical Informatics
Background:
- Patient recruitment for clinical trials (CTs) is often inefficient.
- Traditional information retrieval methods struggle with the semantic complexity of patient-trial matching.
- Large Language Models (LLMs) offer advanced semantic processing capabilities.
Purpose of the Study:
- To investigate the efficacy of LLMs in enhancing patient-to-clinical trial matching.
- To compare LLM-based approaches against traditional methods within an information retrieval pipeline.
- To analyze the trade-offs between effectiveness and computational cost.
Main Methods:
- Utilized a multi-stage retrieval pipeline incorporating BM25, Transformer-based rankers, and LLM-based methods.
- Employed TREC Clinical Trials 2021-23 track collections for evaluation.
- Compared LLM integration in query formulation, filtering, ranking, and re-ranking.
Main Results:
- LLM-based systems, especially with fine-tuned re-ranking, outperformed traditional methods in nDCG and Precision.
- Fine-tuning LLMs improved their ability to identify eligible trials.
- LLM approaches achieved competitive performance with state-of-the-art systems in TREC challenges.
- Increased computational cost and reduced efficiency were observed with LLM usage.
Conclusions:
- LLMs show significant promise for automating and improving patient-to-clinical trial matching.
- Further research is needed to optimize the balance between computational cost and retrieval effectiveness.
Related Concept Videos
Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...


